Cardiovascular medicine
The clinical research activity centers on stable ischemic heart disease and the treatment of atherosclerotic coronary disease in patients receiving standard lipid-lowering care.
- Coronary artery disease
- Ischemic heart disease
- Atherosclerosis
The sponsor’s trial focus includes changes in plaque burden within the coronary circulation and related markers of vascular disease.
Psychiatry and psychotherapeutic care
Research activity also involves psychotherapy in a cardiovascular population, with interest in the use of psilocybin-assisted psychotherapy alongside a comparator treatment.
- Psilocybin therapy
- Midazolam-assisted psychotherapy
- Therapeutic mental health support
This reflects an intersection between mental health interventions and somatic disease management in patients with chronic heart disease.
Lipid management and vascular prevention
The funded research includes patients treated with hypolipidemic therapy, indicating a focus on cholesterol control and prevention of progression in atherosclerotic disease.
- Lipid-lowering therapy
- Secondary prevention
- Coronary plaque regression
Clinical interest extends to vascular outcomes associated with long-term management of cardiometabolic risk.
